Application 206572
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIFLORASONE DIACETATE | DIFLORASONE DIACETATE | OINTMENT;TOPICAL | 0.05% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206572-001 | DIFLORASONE DIACETATE | DIFLORASONE DIACETATE | 0.05% | OINTMENT / TOPICAL | 2015-07-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A206572-001 | DIFLORASONE DIACETATE | 0.05% | OINTMENT / TOPICAL | 2015-07-24 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A206572-001 | DIFLORASONE DIACETATE | 0.05% | OINTMENT / TOPICAL | 2015-07-24 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A206572-001 | DIFLORASONE DIACETATE | 0.05% | OINTMENT / TOPICAL | 2015-07-24 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206572-001 | DIFLORASONE DIACETATE | 0.05% | OINTMENT / TOPICAL | 2015-07-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A206572-001 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A206572-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A206572-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A206572-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A206572-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A206572-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A206572-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A206572-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diflorasone Diacetate | DIFLORASONE DIACETATE | Sun Pharmaceutical Industries, Inc. | b20c9420-8fb4-4a49-93f0-c0e4074d6d71 | 2025-09-22 | Adverse reactions | Diflorasone Diacetate DIFLORASONE DIACETATE |
| Diflorasone Diacetate | DIFLORASONE DIACETATE | Sun Pharmaceutical Industries, Inc. | b304dfca-e840-4c03-8217-73aaa5360277 | 2025-07-03 | Adverse reactions | Diflorasone Diacetate DIFLORASONE DIACETATE |
| psorcon | DIFLORASONE DIACETATE | Sun Pharmaceutical Industries, Inc. | de40cc65-f955-423f-9cbd-bc2245c4f982 | 2025-07-02 | Adverse reactions | DIFLORASONE DIACETATE |
| Diflorasone Diacetate | DIFLORASONE DIACETATE | Rising Pharma Holdings, Inc. | 23eb27a4-157f-4eb5-a390-37586710808f | 2023-05-02 | Adverse reactions | Diflorasone Diacetate DIFLORASONE DIACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 61748-350 | Diflorasone Diacetate | Diflorasone Diacetate | VersaPharm Incorporated | ANDA | Current |